Earum Pharmaceuticals gets nod to acquire 55% stake in Cedac Medicorp

03 Apr 2020 Evaluate

Earum Pharmaceuticals has received approval to acquire Cedac Medicorp a partnership firm engaged in manufacturing of Pharmaceutical products. The company proposes to enter into an agreement to acquire its 55% stake i.e. of the partnership firm Cedac Medicorp manufacture's pharmaceutical products since its formation in 2017 and Cedac Medicorp is located at Ahmedabad. The Board Members of company in their meeting held on April 2, 2020, has considered and approved the same.

Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.

Murae Organisor Share Price

1.66 -0.03 (-1.78%)
25-Apr-2024 15:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.45
Dr. Reddys Lab 6228.00
Cipla 1403.75
Zydus Lifesciences 952.00
Lupin 1593.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.